Investigation of NDM-1 and OXA-48 producing carbapenem resistant Klebsiella pneumoniae ST15 in Iran

被引:2
|
作者
Mohajer, Hedayat Bozorgi [1 ]
Salimizand, Himen [2 ,3 ,5 ]
Gharanizadeh, Dahieh [1 ]
Hossainpanahi, Afra [3 ]
Ramazanzadeh, Rashid [4 ]
机构
[1] Kurdistan Univ Med Sci, Student Res Comm, Sanandaj, Iran
[2] Kurdistan Univ Med Sci, Res Inst Hlth Dev, Cellular & Mol Res Ctr, Sanandaj, Iran
[3] Kurdistan Univ Med Sci, Fac Med, Dept Microbiol, Sanandaj, Iran
[4] Ardabil Univ Med Sci, Fac Med, Dept Microbiol, Ardebil, Iran
[5] Kurdistan Univ Med Sci, Pasdaran Ave,POB 6617713446, Sanandaj, Kurdistan Provi, Iran
关键词
Klebsiella pneumoniae; PCR-based replicon typing; carbapenemase; MLST; high-risk clone; METALLO-BETA-LACTAMASE; 1ST REPORT; ENTEROBACTERIACEAE; EMERGENCE; PCR; HOSPITALS; SPREAD;
D O I
10.1556/030.2023.01945
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this study was to determine the frequency of carbapenem resistant Klebsiella pneumoniae (CRKP) sequence types (STs) in Iran. Samples were collected from three university hospitals in Sanandaj, Iran, from December 2016 to March 2018. Antibiotic susceptibility testing, phenotypic and genotypic detection of carbapenemases were performed. Common K. pneumoniae capsular types were sought for all isolates. The genetic relatedness of isolates was investigated by multilocus sequence typing (MLST). Plasmids were detected by PCR-based Replicon Typing (PBRT). During the study, 67 K. pneumoniae isolates were identified. Of which, 18 (26.9%) isolates were detected as carbapenemresistant. The most effective antibacterial agent was tigecycline (97%, 65 isolates) followed by imipenem and ertapenem (73.13%, 49 isolates). PCR showed that 13 isolates (19.4%) had bla(NDM-1) gene and 5 (7.5%) harbored bla(OXA-48). Examination of common capsular types showed that 2 isolates had K2 and 2 others had K54. REP-PCR revealed 10 clones and 11 singleton strains. MLST analysis of CRKP found ST15 as the most common type (13 isolates, 72.2%), but other STs were also detected namely, ST19, ST117, ST1390, and ST1594. ColE1 and IncL/M plasmids were the carriers of blaNDM- 1 and blaOXA-48, respectively. The results showed that CRKP spread in our health centers. Our results, therefore, indicate a worrying trend of resistance to carbapenems in K. pneumoniae.
引用
收藏
页码:38 / 46
页数:9
相关论文
共 50 条
  • [21] Failure of ceftazidime/avibactam experimental therapy in the treatment of Klebsiella pneumoniae ST11 co-producing NDM-1 and OXA-48 carbapenemases infection
    Nikbin, Vajihe Sadat
    Gholizadeh Khiavi, Elham Haj Agha
    Dehghani-Latani, Mehdi
    Hosseinzadeh, Majid
    Shirzadi, Mohammad
    Pourajam, Samaneh
    Nouri, Samereh
    Solgi, Hamid
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (10) : 2023 - 2027
  • [22] Clonal dissemination of carbapenem-resistant Klebsiella pneumoniae ST16 co-producing NDM-1 and OXA-232 in Thailand
    Abe, Ryuichiro
    Akeda, Yukihiro
    Takeuchi, Dan
    Sakamoto, Noriko
    Sugawara, Yo
    Yamamoto, Norihisa
    Kerdsin, Anusak
    Matsumoto, Yuki
    Motooka, Daisuke
    Leolerd, Warawut
    Santanirand, Pitak
    Suzuki, Masato
    Shibayama, Keigo
    Tomono, Kazunori
    Iida, Tetsuya
    Hamada, Shigeyuki
    JAC-ANTIMICROBIAL RESISTANCE, 2022, 4 (04):
  • [23] Circulation of a Unique Klebsiella pneumoniae Clone, ST147 NDM-1/OXA-48, in Two Diverse Hospitals in Calabria (Italy)
    Nicitra, Emanuele
    Terrana, Morena
    Bongiorno, Dafne
    Dodaro, Saveria
    Greco, Francesca
    Greco, Sonia
    Marascio, Nadia
    Mauro, Maria Vittoria
    Pantanella, Marta
    Privitera, Grete Francesca
    Quirino, Angela
    Serapide, Francesca
    Trecarichi, Enrico Maria
    Vangeli, Valeria
    Mastroianni, Antonio
    Matera, Giovanni
    Russo, Alessandro
    Stefani, Stefania
    ANTIBIOTICS-BASEL, 2025, 14 (02):
  • [24] Spread of OXA-48 and NDM-1-Producing Klebsiella pneumoniae ST48 and ST101 in Chicken Meat in Western Algeria
    Chaalal, Nadia
    Touati, Abdelaziz
    Bakour, Sofiane
    Aissa, Mohamed Amine
    Sotto, Albert
    Lavigne, Jean-Philippe
    Pantel, Alix
    MICROBIAL DRUG RESISTANCE, 2021, 27 (04) : 492 - 500
  • [25] Detection of carbapenem-resistant Escherichia coli and Klebsiella pneumoniae producing NDM-1 in Lebanon
    El-Herte, Rima I.
    Araj, George F.
    Matar, Ghassan M.
    Baroud, Maysa
    Kanafani, Zeina A.
    Kanj, Souha S.
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2012, 6 (05): : 457 - 461
  • [26] Outbreak of carbapenem-resistant Klebsiella pneumoniae producing NDM-1 in a Belgian regional hospital
    Cabaraux, Pierre
    Filipin, Lorenzo
    Willems, Nathalie
    Colombie, Vincent
    Vandergheynst, Frederic
    Place, Sammy
    ACTA CLINICA BELGICA, 2018, 73 : 71 - 71
  • [27] Emergence of Klebsiella pneumoniae co-producing NDM-1, OXA-48, CTX-M-15, CMY-16, QnrA and ArmA in Switzerland
    Seiffert, Salome N.
    Marschall, Jonas
    Perreten, Vincent
    Carattoli, Alessandra
    Furrer, Hansjakob
    Endimiani, Andrea
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 44 (03) : 260 - 262
  • [28] Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection
    Shaw, Evelyn
    Rombauts, Alexander
    Tubau, Fe
    Padulles, Ariadna
    Camara, Jordi
    Lozano, Toni
    Cobo-Sacristan, Sara
    Sabe, Nuria
    Grau, Imma
    Rigo-Bonnin, Raul
    Angeles Dominguez, M.
    Carratala, Jordi
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2018, 73 (04) : 1104 - 1106
  • [29] In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains
    Fatma Erdem
    Ayham Abulaila
    Zerrin Aktas
    Oral Oncul
    Antimicrobial Resistance & Infection Control, 9
  • [30] In vitro evaluation of double carbapenem and colistin combinations against OXA-48, NDM carbapenemase-producing colistin-resistant Klebsiella pneumoniae strains
    Erdem, Fatma
    Abulaila, Ayham
    Aktas, Zerrin
    Oncul, Oral
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2020, 9 (01)